ENDOGENOUS CONTROL OF EPILEPSY - THE NIGRAL INHIBITORY SYSTEM

[81] INVOLVEMENT OF INTRATHALAMIC GABA(B) NEUROTRANSMISSION IN THE CONTROL OF ABSENCE SEIZURES IN THE RAT [J]. NEUROSCIENCE, 1992, 48 (01) : 87 - 93

[82] EVIDENCE FOR A CRITICAL ROLE OF GABAERGIC TRANSMISSION WITHIN THE THALAMUS IN THE GENESIS AND CONTROL OF ABSENCE SEIZURES IN THE RAT [J]. BRAIN RESEARCH, 1991, 545 (1-2) : 1 - 7

[83] LIU Z, 1990, EUR J PHARMACOL, V182, P109

[84] WHICH ANIMAL-MODELS SHOULD BE USED IN THE SEARCH FOR NEW ANTIEPILEPTIC DRUGS - A PROPOSAL BASED ON EXPERIMENTAL AND CLINICAL CONSIDERATIONS [J]. EPILEPSY RESEARCH, 1988, 2 (03) : 145 - 181

[85] EFFECT OF MICROINJECTIONS OF GAMMA-VINYL GABA OR ISONIAZID INTO SUBSTANTIA-NIGRA ON THE DEVELOPMENT OF AMYGDALA KINDLING IN RATS [J]. EXPERIMENTAL NEUROLOGY, 1987, 95 (03) : 622 - 638

[86] FURTHER EVIDENCE FOR ABNORMAL GABAERGIC CIRCUITS IN AMYGDALA-KINDLED RATS [J]. BRAIN RESEARCH, 1987, 420 (02) : 385 - 390

[87] DRUG-INDUCED CHANGES IN GABA CONTENT OF NERVE-ENDINGS IN 11 RAT-BRAIN REGIONS, CORRELATION TO PHARMACOLOGICAL EFFECTS [J]. NEUROSCIENCE LETTERS, 1984, 47 (03) : 325 - 331

[88] EVIDENCE FOR IMPAIRED GABAERGIC ACTIVITY IN THE SUBSTANTIA NIGRA OF AMYGDALOID KINDLED RATS [J]. BRAIN RESEARCH, 1985, 339 (01) : 146 - 150

[89] ANTICONVULSANT AND PROCONVULSANT EFFECTS OF INHIBITORS OF GABA DEGRADATION IN THE AMYGDALA-KINDLING MODEL [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 163 (01) : 1 - 14

[90] INVIVO EFFECTS OF AMINOOXYACETIC ACID AND VALPROIC ACID ON NERVE-TERMINAL (SYNAPTOSOMAL) GABA LEVELS IN DISCRETE BRAIN-AREAS OF THE RAT - CORRELATION TO PHARMACOLOGICAL ACTIVITIES [J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (10) : 1747 - 1756

[81] INVOLVEMENT OF INTRATHALAMIC GABA(B) NEUROTRANSMISSION IN THE CONTROL OF ABSENCE SEIZURES IN THE RAT [J]. NEUROSCIENCE, 1992, 48 (01) : 87 - 93

[82] EVIDENCE FOR A CRITICAL ROLE OF GABAERGIC TRANSMISSION WITHIN THE THALAMUS IN THE GENESIS AND CONTROL OF ABSENCE SEIZURES IN THE RAT [J]. BRAIN RESEARCH, 1991, 545 (1-2) : 1 - 7

[83] LIU Z, 1990, EUR J PHARMACOL, V182, P109

[84] WHICH ANIMAL-MODELS SHOULD BE USED IN THE SEARCH FOR NEW ANTIEPILEPTIC DRUGS - A PROPOSAL BASED ON EXPERIMENTAL AND CLINICAL CONSIDERATIONS [J]. EPILEPSY RESEARCH, 1988, 2 (03) : 145 - 181

[85] EFFECT OF MICROINJECTIONS OF GAMMA-VINYL GABA OR ISONIAZID INTO SUBSTANTIA-NIGRA ON THE DEVELOPMENT OF AMYGDALA KINDLING IN RATS [J]. EXPERIMENTAL NEUROLOGY, 1987, 95 (03) : 622 - 638

[86] FURTHER EVIDENCE FOR ABNORMAL GABAERGIC CIRCUITS IN AMYGDALA-KINDLED RATS [J]. BRAIN RESEARCH, 1987, 420 (02) : 385 - 390

[87] DRUG-INDUCED CHANGES IN GABA CONTENT OF NERVE-ENDINGS IN 11 RAT-BRAIN REGIONS, CORRELATION TO PHARMACOLOGICAL EFFECTS [J]. NEUROSCIENCE LETTERS, 1984, 47 (03) : 325 - 331

[88] EVIDENCE FOR IMPAIRED GABAERGIC ACTIVITY IN THE SUBSTANTIA NIGRA OF AMYGDALOID KINDLED RATS [J]. BRAIN RESEARCH, 1985, 339 (01) : 146 - 150

[89] ANTICONVULSANT AND PROCONVULSANT EFFECTS OF INHIBITORS OF GABA DEGRADATION IN THE AMYGDALA-KINDLING MODEL [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 163 (01) : 1 - 14

[90] INVIVO EFFECTS OF AMINOOXYACETIC ACID AND VALPROIC ACID ON NERVE-TERMINAL (SYNAPTOSOMAL) GABA LEVELS IN DISCRETE BRAIN-AREAS OF THE RAT - CORRELATION TO PHARMACOLOGICAL ACTIVITIES [J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (10) : 1747 - 1756